Psychedelics as a therapy
Did you know that psychedelics acceptance is just around the corner? Robust and durable beneficial mind-altering properties of single or few-doses psilocybin can be used respectfully by carefully selected young and old individuals.
Let's be clear. Some botanicals including cannabis are currently still listed on Schedule 1 of the United Nations Convention on Psychotropic Substances (1971). Scheduled substances may or may not lack therapeutic effects or may have a high potential for abuse/dependence, and may cause serious adverse effects. Psilocybe mushrooms, on the other hand, are not scheduled under the UN Convention, but many countries introduced specific laws to control them, often leading to criminal charges. However, that is only the snapshot of 50 years old scientific knowledge and political will.
Nowadays, a large body of new reliable scientific proof exists and may soon allow the substance to be re-scheduled since its risk does not correspond with the specific schedule list.
Right to science, the Right to enjoy the highest attainable standard of physical and mental health, and the Right to enjoy the benefits of scientific progress and its applications, are essential components of human rights.
Psilocybin compounds can be safely administered in controlled settings, and several therapeutic applications exist. Many patients could reap enormous benefits from the treatment with these substances administered under medical supervision. Countries like Canada have already approved compassionate medical use with these plants and fungi.
In-depth analysis of more than 75 clinical trials of psychedelic therapies being conducted as of today estimated global potential for psychedelic-based therapies as over 200 bn USD. With over 300 mn people affected by…
